We observed significant differences in colorectal cancer‐specific mortality between KRAS‐wild‐type, KRAS c.34G>T (p.G12C)‐mutated, and other KRAS‐mutated patients in Kaplan–Meier analysis (log‐rank p = 0.0002; Figure 2). This evidence concerns the gene KRAS and colorectal cancer.